Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-12-08
1999-11-23
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 93, 546 94, 546 95, 514290, C07D47104, A61K 31435
Patent
active
059901217
ABSTRACT:
The present invention relates to the new use of 1,2-bridged 1,4-dihydropyridines which are known in some cases, of the general formula (I) ##STR1## in which R.sup.1 to R.sup.4 and a have the meaning indicated in the description, processes for their preparation and their use as medicaments, as selective potassium channel modulators, in particular for the treatment of the central nervous system.
REFERENCES:
patent: 3867393 (1975-02-01), Meyer et al.
patent: 3935220 (1976-01-01), Meyer et al.
patent: 3951988 (1976-04-01), Meyer et al.
patent: 4053614 (1977-10-01), Meyer et al.
patent: 5225566 (1993-07-01), Butera et al.
Porsolt, R.D. et al, `Behavioral Despair in Rats: A New Model Sensitive to Antidepressant Treatments` Eur. J. Pharmacol. 1978, vol. 47, No. 4, pp. 379-391, abstract only.
Etcheberrigaray, E. et al, Annals of the New York Acad. Sci. Dec. 15, 1994, vol. 747, pp. 245-255, online search results relied upon.
Heinemann, U. et al, Epilepsy Res. Suppl. 1992, vol. 9, pp. 107-114, online search results relied upon.
Lee, Y.S. et al, Cellular Signalling, Nov. 1993, 5(6), pp. 803-809, online search results relied upon.
Zhang, H. et al, Pharm. Toxicol. Dec. 1994, vol. 75(6), pp. 327-336, online search results relied upon.
H. Meyer, et al., Liebigs Ann. Chem., pp. 1888-1894, (1977).
P.W.L. Tas, et al., Neuroscience Letters, vol. 94, pp. 279-284, (1988).
Pflugers Archiv. European Journal of Physiology, vol. 429, No. 2, Dec. 1994, pp. 176-182.
J.C. Ellory, et al., Br. J. Pharmacol., vol. 111, pp. 903-905 (1994).
de Vry Jean-Marie-Viktor
Glaser Thomas
Heine Hans-Georg
Junge Bodo
Sommermeyer Henning
Bayer Aktiengesellschaft
Davis Zinna Northington
LandOfFree
Use of 1,2-bridged 1,4-dihydropyridines as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 1,2-bridged 1,4-dihydropyridines as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1,2-bridged 1,4-dihydropyridines as medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222219